From theheart.org on Medscape

Medscape Medical News from the

American College of Cardiology (ACC) 2015 Scientific Sessions

March 14 - 16, 2015; San Diego, California

The Cardiology Show

The Cardiology Show From ACC 2015 With Dr Valentin Fuster UPDATED with Transcript // PROMISE, PEGASUS, and unpronounceable PCSK9 inhibitors are reviewed, but Dr Fuster was most impressed with the LEGACY data on weight loss in AF.

Meeting Highlights at a Glance

Top News From ACC 2015: Slideshow Highlights include high-profile late-breaking data on optimal antiplatelets post-PCI and in chronic CAD, transcatheter aortic-valve replacement, and imaging for suspected chest pain.

Conference News

ACC Adding Age, Sex Criteria Sharpen Statin Guidelines: Analysis
Heartwire from Medscape, March 27, 2015
ACC Trial Has Lessons for Search for 'the Perfect Anticoagulant'
Heartwire from Medscape, March 26, 2015
ACC K-Binder Patiromer Could Keep Patients on HF RAAS Inhibitors
Heartwire from Medscape, March 26, 2015
ACC MOOD-HF: SSRI No Better Than Placebo in Depressed CHF Patients
Heartwire from Medscape, March 25, 2015
ACC AJULAR: Ulnar Access Viable Alternative to Radial for PCI
Heartwire from Medscape, March 24, 2015
ACC Extended Post-PCI DAPT Best in Patients With, Without ACS
Heartwire from Medscape, March 24, 2015
ACC PCI as Good as CABG for Left Main CAD: 5-Year PRECOMBAT Data
Heartwire from Medscape, March 23, 2015
ACC Ablation Bests Amiodarone for Treating AF in Patients with Heart Failure
Heartwire from Medscape, March 20, 2015
ACC MATRIX: Bivalirudin Reduced Mortality vs UFH in ACS Setting
Heartwire from Medscape, March 20, 2015
ACC AF Ablation at MV Surgery Works, but Sans Clinical Gain: Trial
Heartwire from Medscape, March 20, 2015
ACC TOTAL Rejects Routine Thrombectomy at PCI for STEMI
Heartwire from Medscape, March 20, 2015
ACC NOTION: TAVR, Surgery Comparable in Low-Risk Patients
Heartwire from Medscape, March 19, 2015
ACC Baroreflex-Activation Device Shows Promise in Heart Failure
Heartwire from Medscape, March 19, 2015
ACC Five-Year PARTNER Cohort A Data Confirm TAVR Benefit
Heartwire from Medscape, March 18, 2015
ACC MAGNA: Fish-Oil Supplementation May Lower Thrombosis Risk
Heartwire from Medscape, March 17, 2015
ACC No CABG Clinical Gain From Remote Ischemic Preconditioning
Heartwire from Medscape, March 17, 2015
ACC MATRIX: Radial PCI Bests Femoral-Access in ACS Patients
Heartwire from Medscape, March 16, 2015

ACC EMBRACE-STEMI: Novel Agent Fails to Block MI Reperfusion Injury
Heartwire from Medscape, March 16, 2015
ACC CoreValve Still Superior at 2 Years in High-Risk Patients
Heartwire from Medscape, March 16, 2015
ACC Folate Supplementation in HTN May Lower Risk for First Stroke
Heartwire from Medscape, March 16, 2015
ACC LEGACY: Long-term Weight Loss Decreases AF Symptoms
Heartwire from Medscape, March 16, 2015
ACC Treating Sleep Apnea May Cut 6-Month Acute-HF Rehospitalization
Heartwire from Medscape, March 16, 2015
ACC Low Stroke, Mortality Rates With New Sapien Valve
Heartwire from Medscape, March 15, 2015
ACC CTA Improves Diagnostic Certainty in Chest-Pain Patients
Heartwire from Medscape, March 15, 2015
ACC OSLER Studies Trumpet Long-term Efficacy of PCSK9 Inhibitors
Heartwire from Medscape, March 15, 2015
ACC MI Survivors May Be at Risk for Lung, Bladder, Other Cancers
Heartwire from Medscape, March 15, 2015
ACC QuickFlex, QuickSite Lead Flaw at 5 Years: No Electrical Issues
Heartwire from Medscape, March 14, 2015
ACC PEGASUS Shows Ticagrelor Tussle of Reduced Events vs Bleeding
Heartwire from Medscape, March 14, 2015
ACC CTA Does Not Reduce Hard Events vs Functional Tests
Heartwire from Medscape, March 14, 2015
ACC 'Too Much' Sitting May Worsen Coronary Artery Calcification
Heartwire from Medscape, March 11, 2015
ACC ACC 2015: Contemporary Cardiology and San Diego Sunshine
Heartwire from Medscape, March 10, 2015
ACC Antidepressants, Statins Have Separate Impact on CV Mortality
Heartwire from Medscape, March 9, 2015
ACC No CV Risks From Testosterone Treatment in Two Studies
Heartwire from Medscape, March 9, 2015
ACC Omega-3 PUFA Intake May Limit Post-MI Remodeling
Heartwire from Medscape, March 6, 2015

Perspectives from ACC

GARFIELD-AF: Room for Improvement in Both Men and Women
Samuel Z. Goldhaber, MD
London Bridge Is Falling Down
Samuel Z. Goldhaber, MD
Cardiac Cachexia (Wasting) Clarified
Ileana L. Piña, MD, MPH;
Stefan D. Anker, MD, PhD
Insights From ACC 2015 to Lower HF Readmissions
Ileana L. Piña, MD, MPH
PCSK9 Inhibitors: What to Know if They Come to Market
Seth Bilazarian, MD; Marc S Sabatine, MD, MPH
Transcatheter Aortic Valves vs Surgery: Closing the Gap
Susheel K Kodali, MD; Thomas Walther, MD, PhD
LEGACY PI Throws Down the Gauntlet to US Physicians
John M. Mandrola, MD; Prashanthan Sanders, MBBS, PhD
9 Key Primary Care Takeaways From ACC 2015
Laurie Scudder, DNP, NP; John M. Mandrola, MD
Abraham Verghese: Hope for Hands-on Medicine in the EMR Era
John M. Mandrola, MD; Abraham Verghese, MD
ACC15 for Interventional Cards: TOTAL, MATRIX, DANAMI
David E. Kandzari, MD; Gilles Montalescot, MD, PhD
Bob Harrington's ACC: Poetry, PROMISE, and PEGASUS
Robert Harrington, MD
PEGASUS: Ticagrelor Post MI and Precision Medicine
Seth Bilazarian, MD; Marc S. Sabatine, MD, MPH

Bloggers from the Floor

Left Atrial Appendage Closure: Resist the Urge? Dr John Mandrola summarizes and reflects on a study of LAA closure and its outcomes presented at ACC 2015.
How Can We Afford Not to Pay Attention to LEGACY? Dr John Mandola describes the outcome of the LEGACY trial and talks with principal investigator Dr Prash Sanders about the key details to its success.
15 Things All Cardiologists Should Know About Palliative Care Dr Staci Mandrola, Dr John Mandrola's wife, gave a presentation at ACC2015 on palliative care. He summarizes it here.
Dr Abraham Verghese on Treating the Real Heart Dr John Mandrola recounts listening to and being profoundly moved by Dr Abraham Verghese's talk at ACC 2015.
The LEGACY Trial: Why It Should Send Our CMS Accountants Scrambling Dr Melissa Walton-Shirley adds up the cost of conventional AF treatment and compares it with the cost of a structured program for weight loss for AF patients. Guess which wins.
What Should the FDA Do With the PCSK9 Inhibitor Evolocumab? Dr Melissa Walton-Shirley loves the idea of evolocumab, but . . .
First Day of ACC 2015: Questions and Caveats Dr Melissa Walton-Shirley recaps the late-breaking clinical trials and some other presentations on day 1 of ACC 2015.

Live Blog

News and Views from ACC 2015 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage